Cite
HARVARD Citation
Shi, X. et al. (2018). MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor. Cell cycle. 17 (16), pp. 1967-1978. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shi, X. et al. (2018). MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor. Cell cycle. 17 (16), pp. 1967-1978. [Online].